Bruker Closes Stock Offering | GenomeWeb

NEW YORK, April 30 (GenomeWeb News) - Bruker BioSciences announced at the close of market yesterday that it has closed its public offering of 17.3 million shares.

 

Of the shares, 3.5 million were sold by the company and 13.8 million by four stockholders related to CEO Frank Laukien. The stock was priced at $4.50 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.